These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38366898)

  • 1. Non-psychotic Outcomes in Young People at Ultra-High Risk of Developing a Psychotic Disorder: A Long-Term Follow-up Study.
    Spiteri-Staines AE; Yung AR; Lin A; Hartmann JA; Amminger P; McGorry PD; Thompson A; Wood SJ; Nelson B
    Schizophr Bull; 2024 Feb; ():. PubMed ID: 38366898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis.
    Rutigliano G; Valmaggia L; Landi P; Frascarelli M; Cappucciati M; Sear V; Rocchetti M; De Micheli A; Jones C; Palombini E; McGuire P; Fusar-Poli P
    J Affect Disord; 2016 Oct; 203():101-110. PubMed ID: 27285723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.
    Nelson B; Yuen HP; Wood SJ; Lin A; Spiliotacopoulos D; Bruxner A; Broussard C; Simmons M; Foley DL; Brewer WJ; Francey SM; Amminger GP; Thompson A; McGorry PD; Yung AR
    JAMA Psychiatry; 2013 Aug; 70(8):793-802. PubMed ID: 23739772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline grey matter volume of non-transitioned "ultra high risk" for psychosis individuals with and without attenuated psychotic symptoms at long-term follow-up.
    Cropley VL; Lin A; Nelson B; Reniers RLEP; Yung AR; Bartholomeusz CF; Klauser P; Velakoulis D; McGorry P; Wood SJ; Pantelis C
    Schizophr Res; 2016 Jun; 173(3):152-158. PubMed ID: 26032566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
    McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
    Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes.
    Youn S; Phillips LJ; Amminger GP; Berger G; Chen EYH; de Haan L; Hartmann JA; Hickie IB; Lavoie S; Markulev C; McGorry PD; Mossaheb N; Nieman DH; Nordentoft M; Riecher-Rössler A; Schäfer MR; Schlögelhofer M; Smesny S; Thompson A; Verma S; Yuen HP; Yung AR; Nelson B
    Schizophr Res; 2020 Feb; 216():255-261. PubMed ID: 31866077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood maltreatment and transition to psychotic disorder independently predict long-term functioning in young people at ultra-high risk for psychosis.
    Yung AR; Cotter J; Wood SJ; McGorry P; Thompson AD; Nelson B; Lin A
    Psychol Med; 2015 Dec; 45(16):3453-65. PubMed ID: 26166153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term employment among people at ultra-high risk for psychosis.
    Cotter J; Lin A; Drake RJ; Thompson A; Nelson B; McGorry P; Wood SJ; Yung AR
    Schizophr Res; 2017 Jun; 184():26-31. PubMed ID: 27903412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adolescents at ultra-high risk for psychosis: long-term outcome of individuals who recover from their at-risk state.
    de Wit S; Schothorst PF; Oranje B; Ziermans TB; Durston S; Kahn RS
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):865-73. PubMed ID: 24636460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Borderline personality features and development of psychosis in an 'ultra high risk' (UHR) population: a case control study.
    Thompson A; Nelson B; Bechdolf A; Chanen AM; Domingues I; McDougall E; Yung AR
    Early Interv Psychiatry; 2012 Aug; 6(3):247-55. PubMed ID: 22672502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of non-psychotic disorders in ultra-high risk individuals and transition to psychosis: A systematic review.
    Albert U; Tomassi S; Maina G; Tosato S
    Psychiatry Res; 2018 Dec; 270():1-12. PubMed ID: 30243126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis.
    Lin A; Yung AR; Nelson B; Brewer WJ; Riley R; Simmons M; Pantelis C; Wood SJ
    Psychol Med; 2013 Nov; 43(11):2349-60. PubMed ID: 23388122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxoplasma gondii, Herpesviridae and long-term risk of transition to first-episode psychosis in an ultra high-risk sample.
    Burkhardt E; Berger M; Yolken RH; Lin A; Yuen HP; Wood SJ; Francey SM; Thompson A; McGorry PD; Nelson B; Yung AR; Amminger GP
    Schizophr Res; 2021 Jul; 233():24-30. PubMed ID: 34225023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four-Year Follow-up of Cognitive Behavioral Therapy in Persons at Ultra-High Risk for Developing Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.
    Ising HK; Kraan TC; Rietdijk J; Dragt S; Klaassen RM; Boonstra N; Nieman DH; Willebrands-Mendrik M; van den Berg DP; Linszen DH; Wunderink L; Veling W; Smit F; van der Gaag M
    Schizophr Bull; 2016 Sep; 42(5):1243-52. PubMed ID: 26994397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.
    Yung AR; Yuen HP; McGorry PD; Phillips LJ; Kelly D; Dell'Olio M; Francey SM; Cosgrave EM; Killackey E; Stanford C; Godfrey K; Buckby J
    Aust N Z J Psychiatry; 2005; 39(11-12):964-71. PubMed ID: 16343296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critique of the "ultra-high risk" and "transition" paradigm.
    van Os J; Guloksuz S
    World Psychiatry; 2017 Jun; 16(2):200-206. PubMed ID: 28498576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis.
    Lin A; Wood SJ; Nelson B; Beavan A; McGorry P; Yung AR
    Am J Psychiatry; 2015 Mar; 172(3):249-58. PubMed ID: 25727537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
    Bolt LK; Amminger GP; Farhall J; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.